ALCON
Kalypsys has a multi-year discovery collaboration agreement with Alcon, the world’s leading eye care company, to deliver ophthalmic drug candidates for development and commercialization. Kalypsys will use the epiK™ discovery platform to identify and profile active molecules against collaboration targets. Kalypsys will also apply its medicinal chemistry and other drug discovery capabilities in partnership with Alcon’s research capabilities and expertise in ophthalmology. Alcon is responsible for the development, manufacturing, and commercialization of products. “In our view, Kalypsys offers a unique combination of an experienced management team and world-class pharmaceutical technology to create a powerful drug discovery engine that we envision will help grow and advance our expected pipeline of novel and important drugs to treat diseases of the eye”, said Martin B. Wax M.D., Alcon’s Vice President of R&D and head of Ophthalmology Discovery Research.
PANASONIC
Kalypsys, Inc. and Panasonic Factory Solutions Company have a partnership to design and market the next generation in drug discovery automation. Panasonic is the world’s #1 company in the R&D of technology, based both on R&D expenditures and patents granted. While well known for its consumer products, Panasonic is also the world’s largest manufacturer of electronic assemblies and a leader in automation for this market. Moreover, Panasonic is also the major supplier of automation to the Japanese life science market, with an installed base of over 50 drug discovery systems. Kalypsys Systems and Panasonic are collaborating not only with each other, but with leading researchers, automation experts, drug discovery scientists, other equipment vendors, and influential thinkers in the life sciences. Kalypsys Systems and Panasonic are working to create a new product line to improve the productivity of researchers in the life sciences.
KALYPSYS SYSTEMS
Kalypsys is a leading innovator in the area of drug discovery and utilizes some of the most advanced and robust drug discovery automation tools in the industry. The Kalypsys Systems Group was formed to market these tools to researchers in pharmaceutical and academic research institutions. Satisfied Kalypsys’ customers include a number of prestigious organizations including The National Institutes of Health, Los Alamos National Laboratories, The Scripps Research Institute, Florida and Merck Research Laboratories. Purchasing a Kalypsys System means entering into an integrated and user friendly relationship to allow you to expand your technology capabilities as your drug discovery or profiling needs expand. Many of our Systems partners find that they want to integrate new hardware or software capabilities following the purchase of their first Kalypsys System, and the Kalypsys Systems Group and the Kalypsys informatics team are here to respond to the evolving technology needs of our partners. Back to top
